Stotles logo
Stale pre-tender

IT services: consulting, software development, Internet and support

Published

Description

Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a 5-year technical strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the pilot is expected to be circa 6 months. Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a 5-year technical strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the Pilot is expected to be circa 6 months. Having been fully dependent on Public Health England (PHE) ICT services and infrastructure since its inception in 2015, it is strategically important for PBL to now establish a completely new and independent ICT operation. The following technical strategy has been approved for implementation. Within the limited scope of a Pilot phase, ICT services organisations are invited to express an interest in designing, supplying and building this environment in close collaboration with a dedicated PBL team, on a fixed-price basis. — HCI-based hosting platform – currently specified as Dell-EMC VxRail stretch-cluster, — physical network underlay (limited scope), — perimeter firewall (to be specified), — SDN network overlay technology (circa 30 endpoints) – currently specified as Cisco’s SDA solution, — Horizon VDI for application and desktop virtualisation (2-3 pilot application environments). — MS Windows domain(s) dedicated to PBL – including all domain-related services and inter-domain trust for testing purposes, — coherent IDAM/RBAC ecosystem. The Pilot infrastructure will form the basis of a broader enterprise ICT core infrastructure that will be built-out in subsequent programme phases. PBL operates within a highly regulated pharmaceutical environment (within FDA and MHRA codes/guidance for GMP IT). Close collaboration with PBL and adherence to ITIL principles and local IT infrastructure qualification controls will be critical to ensure compliance with regulatory standards from day-1.

Timeline

Publish date

5 years ago

Buyer information

Porton Biopharma Ltd

Email:
jeff.pike@portonbiopharma.com

Explore contracts and tenders relating to Porton Biopharma Ltd

Go to buyer profile
To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore similar tenders and contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

Explore other contracts published by Porton Biopharma Ltd

Explore more open tenders, recent contract awards and upcoming contract expiries published by Porton Biopharma Ltd.

Explore more suppliers to Porton Biopharma Ltd

Sign up